Skip to content
healthcare.dev

Cerdelga

NDC 58468-0220, eliglustat, capsule, from Genzyme Corporation.

Product NDC
58468-0220
Status
Listed
Labeler
Genzyme Corporation
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA205494
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/58468-0220 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ELIGLUSTAT84 mg/1

Pharmacologic classes

Cytochrome P450 2D6 Inhibitors [MoA]; Glucosylceramide Synthase Inhibitor [EPC]; Glucosylceramide Synthase Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

Package NDCNDC-11Package
58468-0220-1584680220014 BLISTER PACK in 1 CARTON (58468-0220-1) / 14 CAPSULE in 1 BLISTER PACK
58468-0220-2584680220021 BLISTER PACK in 1 CARTON (58468-0220-2) / 14 CAPSULE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/819f828a-b888-4e46-83fc-94d774a28a83

Use it

Look up 58468-0220 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/58468-0220 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 58468-0220. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.